Although MTX was initially introduced as a chemotherapeutic agent for the treatment of malignancies, it is clear that, in the doses used, the mechanism of action in the suppression of inflammation ...

Place of rank ligand inhibitor in giant cell tumour of bone. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a full text component.

Biosimilar DMARDs offer cost-effective and improved outcomes over leflunomide for RA patients unresponsive to methotrexate. The study used a Markov model with data from 25,099 RA patients to simulate ...

Please provide your email address to receive an email when new articles are posted on . Patients with RA treated with first-line upadacitinib over 5 years had greater reductions in disease activity vs ...

Leflunomide and methotrexate are prescription drugs used to treat rheumatoid arthritis (RA). Methotrexate is also used to treat certain other conditions, including psoriasis. This article explains the ...